The Searle Company Limited has released its quarterly financial statements for the period ended September 30, 2026, reporting a slight decline in revenue but stable profitability metrics.
- Revenue for the quarter was PKR 8,452.70M, down from PKR 8,567.32M in the same period last year.
- Gross profit margin decreased slightly to 55.67% from 55.90% year-on-year.
- Profit after tax (PAT) increased to PKR 865.54M compared to PKR 853.52M in the previous year.
- Earnings per share (EPS) rose to PKR 1.47 from PKR 1.45.
- Distribution and administrative expenses decreased by 3% year-on-year, reflecting cost discipline.
- The report is un-audited and follows IAS 34 standards for interim financial reporting.
- The company aims to enhance operational efficiency and expand its pharmaceutical portfolio in FY2027.